Brief: Zelluna Receives Positive Feedback From UK's MHRA
Oct 9 (Reuters) - Zelluna ASA ZLNA.OL: RECEIVES POSITIVE FEEDBACK FROM UK'S MHRA FEEDBACK SUPPORTS ZELLUNA'S PLANNED CTA SUBMISSION FOR ZI-MA4-1 ON TRACK TO FILE CTA BY YEAR END 2025 Source text: ID:nGNEb9mBr3 Further company coverage: ZLNA.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Zelluna ASA
See all newsNorway's Zelluna ASA reports Q2 loss
Brief: Zelluna Reports Q2 Total Loss Of NOK 19.7 Million
Brief: Zelluna Says IDMC Recommends Recruitment Of Next Two Patients At First Dose Level
Brief: Zelluna Says First Patient Dosed With Zi-Ma4-1 In Zima-101 Phase 1 Trial
Brief: Zelluna Wins NOK 16 Mln Research Council Of Norway Grant